DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 32 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 325,000 | $1,404,000 | 2.87% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 198,730 | $858,514 | 0.97% |
| Bleichroeder LP | 294,117 | $1,270,585 | 0.26% |
| EAM Investors, LLC | 270,419 | $1,168,210 | 0.22% |
| COOPERMAN LEON G | 875,993 | $3,784,290 | 0.20% |
| CATALYST FINANCIAL PARTNERS LLC | 36,267 | $156,673 | 0.06% |
| Legend Financial Advisors, Inc. | 1,000 | $4,320 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 124,744 | $538,894 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 4,824 | $20,840 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,240 | $26,957 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $798,638 | 0.00% |
| STATE STREET CORP | 66,629 | $287,837 | 0.00% |
| TORONTO DOMINION BANK | 24 | $0 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13,251 | $57,244 | 0.00% |
| MORGAN STANLEY | 57,100 | $246,672 | 0.00% |
| BlackRock Inc. | 71,915 | $310,673 | 0.00% |
| Bank of New York Mellon Corp | 35,894 | $155,062 | 0.00% |
| Citadel Advisors | 7,000 | $30,240 | 0.00% |
| Citadel Advisors | 200 | $864 | 0.00% |
| Citadel Advisors | 7,912 | $34,180 | 0.00% |
External links
This page lists DIAMEDICA THERAPEUTICS INC's shareholders in Q2 2023. To view DIAMEDICA THERAPEUTICS INC's shareholder history, click here.